OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Developments in anti-complement therapy; from disease to clinical trial
Claire L. Harris, Richard B. Pouw, David Kavanagh, et al.
Molecular Immunology (2018) Vol. 102, pp. 89-119
Open Access | Times Cited: 81

Showing 1-25 of 81 citing articles:

Innate immunity in diabetic kidney disease
Sydney C.W. Tang, Wai Han Yiu
Nature Reviews Nephrology (2020) Vol. 16, Iss. 4, pp. 206-222
Closed Access | Times Cited: 399

New insights into the immune functions of complement
Edimara S. Reis, Dimitrios C. Mastellos, George Hajishengallis, et al.
Nature reviews. Immunology (2019) Vol. 19, Iss. 8, pp. 503-516
Open Access | Times Cited: 391

Clinical promise of next-generation complement therapeutics
Dimitrios C. Mastellos, Daniel Ricklin, John D. Lambris
Nature Reviews Drug Discovery (2019) Vol. 18, Iss. 9, pp. 707-729
Open Access | Times Cited: 293

Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics
Peter Garred, Andrea J. Tenner, Tom Eirik Mollnes
Pharmacological Reviews (2021) Vol. 73, Iss. 2, pp. 792-827
Open Access | Times Cited: 134

Tipping the balance: intricate roles of the complement system in disease and therapy
Richard B. Pouw, Daniel Ricklin
Seminars in Immunopathology (2021) Vol. 43, Iss. 6, pp. 757-771
Open Access | Times Cited: 116

Compendium of current complement therapeutics
Wioleta M. Zelek, Long Xie, B. Paul Morgan, et al.
Molecular Immunology (2019) Vol. 114, pp. 341-352
Open Access | Times Cited: 139

Immunological Basis of the Endometriosis: The Complement System as a Potential Therapeutic Target
Chiara Agostinis, Andrea Balduit, Alessandro Mangogna, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 80

Compstatins: the dawn of clinical C3-targeted complement inhibition
Christina Lamers, Dimitrios C. Mastellos, Daniel Ricklin, et al.
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 8, pp. 629-640
Open Access | Times Cited: 49

Eculizumab and Beyond: The Past, Present, and Future of Complement Therapeutics
Christopher J. Patriquin, Kevin H.M. Kuo
Transfusion Medicine Reviews (2019) Vol. 33, Iss. 4, pp. 256-265
Closed Access | Times Cited: 60

The role of complement membrane attack complex in dry and wet AMD - From hypothesis to clinical trials
Rajendra Kumar‐Singh
Experimental Eye Research (2019) Vol. 184, pp. 266-277
Open Access | Times Cited: 56

Biomaterial and cellular implants: foreign surfaces where immunity and coagulation meet
Jayachandran N. Kizhakkedathu, Edward M. Conway
Blood (2021) Vol. 139, Iss. 13, pp. 1987-1998
Open Access | Times Cited: 42

Complement System: An Immunotherapy Target in Colorectal Cancer
Iman M. Talaat, Noha Mousaad Elemam, Maha Saber-Ayad
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 35

Complement factor I: Regulatory nexus, driver of immunopathology, and therapeutic
Thomas M Hallam, Stephen J. Sharp, Aikaterini Andreadi, et al.
Immunobiology (2023) Vol. 228, Iss. 5, pp. 152410-152410
Open Access | Times Cited: 21

Complement‐targeted therapeutics: An emerging field enabled by academic drug discovery
Christina Lamers, Daniel Ricklin, John D. Lambris
American Journal of Hematology (2023) Vol. 98, Iss. S4
Open Access | Times Cited: 19

The contribution of the alternative pathway in complement activation on cell surfaces depends on the strength of classical pathway initiation
Esther C. W. de Boer, Astrid J.F. Thielen, Jeroen D. Langereis, et al.
Clinical & Translational Immunology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 17

The human factor H protein family – an update
Noémi Sándor, Andrea Schneider, Alexandra T. Matola, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8

C3d-Targeted factor H inhibits tissue complement in disease models and reduces glomerular injury without affecting circulating complement
Fei Liu, Sarah T. Ryan, Kelly C. Fahnoe, et al.
Molecular Therapy (2024) Vol. 32, Iss. 4, pp. 1061-1079
Open Access | Times Cited: 7

Complement dysregulation in glomerulonephritis
Kati Kaartinen, Adrian Safa, Soumya Kotha, et al.
Seminars in Immunology (2019) Vol. 45, pp. 101331-101331
Open Access | Times Cited: 51

Treatment of Rare Inflammatory Kidney Diseases: Drugs Targeting the Terminal Complement Pathway
Marion Anliker‐Ort, Jasper Dingemanse, John van den Anker, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 45

The C5a/C5aR2 axis promotes renal inflammation and tissue damage
Ting Zhang, Kunyi Wu, Ning Ma, et al.
JCI Insight (2020) Vol. 5, Iss. 7
Open Access | Times Cited: 40

Broadly effective metabolic and immune recovery with C5 inhibition in CHAPLE disease
Ahmet Özen, Nurhan Kasap, Ivan Vujkovic-Cvijin, et al.
Nature Immunology (2021) Vol. 22, Iss. 2, pp. 128-139
Open Access | Times Cited: 37

Aberrant Complement System Activation in Neurological Disorders
Karolina Ziąbska, Małgorzata Ziemka‐Nałęcz, Paulina Pawelec, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4675-4675
Open Access | Times Cited: 35

Gene targeting as a therapeutic avenue in diseases mediated by the complement alternative pathway
Anna K. Dreismann, Thomas M Hallam, Lawrence C. S. Tam, et al.
Immunological Reviews (2022) Vol. 313, Iss. 1, pp. 402-419
Open Access | Times Cited: 24

Role of complement in diabetes
Ramzi Ajjan, Verena Schroeder
Molecular Immunology (2019) Vol. 114, pp. 270-277
Open Access | Times Cited: 42

Complement and CD4+ T cells drive context-specific corneal sensory neuropathy
Derek J. Royer, Jose Echegaray-Mendez, Liwen Lin, et al.
eLife (2019) Vol. 8
Open Access | Times Cited: 41

Page 1 - Next Page

Scroll to top